Tao Sheng

530 total citations
12 papers, 152 citations indexed

About

Tao Sheng is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Tao Sheng has authored 12 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Tao Sheng's work include Gastric Cancer Management and Outcomes (6 papers), Gastrointestinal Tumor Research and Treatment (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Tao Sheng is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), Gastrointestinal Tumor Research and Treatment (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Tao Sheng collaborates with scholars based in China, United States and Puerto Rico. Tao Sheng's co-authors include Yanan Tian, Sui Ke, Min Chen, Zhihai Peng, Shuang Liu, Xing Sun, Xiaogang Wang, Tao Li, Zijun Gong and Bin Hu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

Tao Sheng

11 papers receiving 151 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tao Sheng China	5	52	32	28	27	18	12	152
Atsuro Takeshita Japan	9	46 0.9×	28 0.9×	68 2.4×	28 1.0×	17 0.9×	23	212
Omar García-Sánchez Spain	5	86 1.7×	11 0.3×	19 0.7×	20 0.7×	20 1.1×	7	205
Junyi Wang China	6	37 0.7×	30 0.9×	31 1.1×	60 2.2×	21 1.2×	14	228
Noori Maka United Kingdom	4	52 1.0×	25 0.8×	28 1.0×	15 0.6×	6 0.3×	18	213
Daopeng Yang China	5	38 0.7×	12 0.4×	14 0.5×	28 1.0×	12 0.7×	19	375
Praveen Jain India	8	19 0.4×	65 2.0×	71 2.5×	11 0.4×	40 2.2×	23	164
Adrian Tulin Romania	7	55 1.1×	23 0.7×	47 1.7×	53 2.0×	20 1.1×	37	202
Alessandra Meddis Denmark	5	28 0.5×	63 2.0×	32 1.1×	11 0.4×	49 2.7×	10	141
Jiali Lv China	10	69 1.3×	45 1.4×	30 1.1×	29 1.1×	31 1.7×	29	221
Benito Fabio Mirto Italy	6	66 1.3×	43 1.3×	82 2.9×	57 2.1×	51 2.8×	13	222

Countries citing papers authored by Tao Sheng

Since Specialization

Citations

This map shows the geographic impact of Tao Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Sheng more than expected).

Fields of papers citing papers by Tao Sheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Sheng. The network helps show where Tao Sheng may publish in the future.

Co-authorship network of co-authors of Tao Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Sheng. A scholar is included among the top collaborators of Tao Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Sheng. Tao Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Moehler, Markus, Do‐Youn Oh, Ken Kato, et al.. (2025). First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-305. Advances in Therapy. 42(5). 2248–2268. 2 indexed citations

Correa, Marcia Cruz, Markus Moehler, Do‐Youn Oh, et al.. (2025). Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment of advanced gastric or gastroesophageal junction adenocarcinoma: patient-reported outcomes in the RATIONALE-305 study. Current Medical Research and Opinion. 41(6). 1007–1016. 2 indexed citations

Moehler, Markus, D-Y. Oh, Kazuyoshi Kato, et al.. (2024). 397MO Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT in HER2-negative advanced or metastatic gastric or gastro-esophageal junction adenocarcinoma (GC/GEJC): PD-L1 biomarker analysis from RATIONALE-305. Annals of Oncology. 35. S160–S161. 7 indexed citations

Cruz‐Correa, Marcia, D-Y. Oh, Ken Kato, et al.. (2024). 1437P Tislelizumab (TIS) + chemotherapy (CT) vs placebo (PBO) + CT in HER2-negative advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GC/GEJC): RATIONALE-305 study minimum 3-year survival follow-up. Annals of Oncology. 35. S893–S894. 4 indexed citations

Arkenau, Hendrik‐Tobias, Josep Tabernero, Marcia Cruz‐Correa, et al.. (2024). Tislelizumab plus chemotherapy (chemo) versus placebo plus chemo as first-line treatment for locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: RATIONALE-305 European/North American patient subgroup.. Journal of Clinical Oncology. 42(3_suppl). 330–330. 1 indexed citations

Cruz‐Correa, Marcia, Rui‐Hua Xu, Markus Moehler, et al.. (2024). Tislelizumab (TIS) plus chemotherapy (Chemo) vs placebo (PBO) plus chemo as first-line (1L) treatment of advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJC): Health-related quality of life (HRQoL) outcomes in the RATIONALE-305 study.. Journal of Clinical Oncology. 42(3_suppl). 290–290. 1 indexed citations

Li, Linjin, et al.. (2023). Long-term outcomes of radiofrequency ablation vs. partial nephrectomy for cT1 renal cancer: A meta-analysis and systematic review. Frontiers in Surgery. 9. 1012897–1012897. 5 indexed citations

Wang, Fei, et al.. (2022). Comparison of the Oncological and Functional Outcomes of Brachytherapy and Radical Prostatectomy for Localized Prostate Cancer. Medicina. 58(10). 1387–1387. 2 indexed citations

He, Yanmei, et al.. (2020). TVT‐O vs TVT‐S for female stress urinary incontinence: A systematic review and meta‐analysis. International Journal of Clinical Practice. 74(9). e13506–e13506.

10.

Liu, Shuang, Tonghai Xing, Tao Sheng, et al.. (2014). The reduction rate of serum C3 following liver transplantation is an effective predictor of non-anastomotic strictures. Hepatology International. 8(2). 293–300. 2 indexed citations

11.

Liu, Shuang, Xiaogang Wang, Tao Li, et al.. (2013). The effects of intraoperative cryoprecipitate transfusion on acute renal failure following orthotropic liver transplantation. Hepatology International. 7(3). 901–909. 56 indexed citations

12.

Tian, Yanan, Sui Ke, Min Chen, & Tao Sheng. (2003). Interactions between the Aryl Hydrocarbon Receptor and P-TEFb. Journal of Biological Chemistry. 278(45). 44041–44048. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact